HEART SENTRY - By lexingtonBioSciences.com

Thursday, July 5, 2018

The Donald's lack of vision in negotiations puts the USA at a distinct disadvantage!

By David Honig

I'm going to get a little wonky and write about Donald Trump and negotiations. For those who don't know, I'm an adjunct professor at Indiana University - Robert H. McKinney School of Law and I teach negotiations. 

Trump, as most of us know, is the credited author of "The Art of the Deal," a book that was actually ghost written by a man named Tony Schwartz, who was given access to Trump and wrote based upon his observations. If you've read The Art of the Deal, or if you've followed Trump lately, you'll know, even if you didn't know the label, that he sees all deal making as what we call

 "distributive bargaining."


Distributive bargaining always has a winner and a loser. It happens when there is a fixed quantity of something and two sides are fighting over how it gets distributed. Think of it as a pie and you're fighting over who gets how many pieces. 

In Trump's world, the bargaining was for a building, or for construction work, or subcontractors. He perceives a successful bargain as one in which there is a winner and a loser, so if he pays less than the seller wants, he wins. The more he saves the more he wins.


The other type of bargaining is called integrative bargaining.

 In integrative bargaining the two sides don't have a complete conflict of interest, and it is possible to reach mutually beneficial agreements. Think of it, not a single pie to be divided by two hungry people, but as a baker and a caterer negotiating over how many pies will be baked at what prices, and the nature of their ongoing relationship after this one gig is over.

The problem with Trump is that he sees only distributive bargaining in an international world that requires integrative bargaining. 


 He can raise tariffs, but so can other countries. He can't demand they not respond. There is no defined end to the negotiation and there is no simple winner and loser. There are always more pies to be baked. 
Further, negotiations aren't binary. China's choices aren't (a) buy soybeans from US farmers, or (b) don't buy soybeans. They can also (c) buy soybeans from Russia, or Argentina, or Brazil, or Canada, etc. That completely strips the distributive bargainer of his power to win or lose, to control the negotiation.

One of the risks of distributive bargaining is bad will. In a one-time distributive bargain, e.g. negotiating with the cabinet maker in your casino about whether you're going to pay his whole bill or demand a discount, you don't have to worry about your ongoing credibility or the next deal. If you do that to the cabinet maker, you can bet he won't agree to do the cabinets in your next casino, and you're going to have to find another cabinet maker.
 There isn't another Canada.

So when you approach international negotiation, in a world as complex as ours, with integrated economies and multiple buyers and sellers, you simply must approach them through integrative bargaining. If you attempt distributive bargaining, success is impossible. And we see that already.

Trump has raised tariffs on China. China responded, in addition to
raising tariffs on US goods, by dropping all its soybean orders from the US and buying them from Russia. The effect is not only to cause tremendous harm to US farmers, but also to increase Russian revenue, making Russia less susceptible to sanctions and boycotts, increasing its economic and political power in the world, and reducing ours. 

Trump saw steel and aluminum and thought it would be an easy win, BECAUSE HE SAW ONLY STEEL AND ALUMINUM - HE SEES EVERY NEGOTIATION AS DISTRIBUTIVE. China saw it as integrative, and integrated Russia and its soybean purchase orders into a far more complex negotiation ecosystem.

Trump has the same weakness politically. For every winner there must be a loser. And that's just not how politics works, not over the long run.

For people who study negotiations, this is incredibly basic stuff, negotiations 101, definitions you learn before you even start talking about styles and tactics. And here's another huge problem for us.

Trump is utterly convinced that his experience in a closely held real estate company has prepared him to run a nation, and therefore he rejects the advice of people who spent entire careers studying the nuances of international negotiations and diplomacy. But the leaders on the other side of the table have not eschewed expertise, they have embraced it. And that means they look at Trump and, given his very limited tool chest and his blindly distributive understanding of negotiation, they know exactly what he is going to do and exactly how to respond to it. 

From a professional negotiation point of view, Trump isn't even bringing checkers to a chess match. He's bringing a quarter that he insists on flipping for heads or tails, while everybody else is studying the chess board to decide whether its better to open with Najdorf or Grünfeld.

Thursday, June 21, 2018

Trade Wars never end well - History shows us why!

History's Not on the Market's Side in a Trade War - Article at Bloomberg

 

The first shots of a global trade war were fired on Friday as U.S. President Donald Trump announced a 25 percent levy on $50 billion of imports from China. The tariffs focus on “industrially significant technology,” and intend to hurt China for alleged theft of intellectual property rights. China responded within hours with a detailed list of imports from the U.S. valued at $50 billion that it would impose a similar 25 percent tax on...

More....@Bloomberg 





Trumps Trade War makes no sense....

Washington Post


A Trade War with China damages both sides...

New York Times Article... 


Markets begin to take Trade War Seriously...

Wall Street Journal 
 

Trump's Trade War will hurt Economy....

Why Donald Trump's trade wars are so risky now... 

Time

Wednesday, February 28, 2018

Lexington BoiSciences "Heart Sentry" Device may be the answer to pre-detection of heart disease!


Lexington Bio Sciences (LexingtonBioSciences.com)

CSE-LNB or OTC-LXGTF 

Heart Disease and Heart Attacks are the number one killer of North Americans, and most people, worldwide. Nearly 1 in 3 deaths in the USA alone are attributed to Heart Attack and Stroke!

For 50% of these people, their "first" indication of a problem is a massive heart attack.  They have no warning whatsoever.

Though taking blood pressure and heart rates coupled with ultrasound techniques will sometimes indicate a problem, the fact remains that, only in 50% of all cases do these indicators work. Now, wouldn't it be great if there was a "Non-invasive" way of determining, with a lot more accuracy, if heart disease is prevalent in a patient, "before" the onset of a heart attack? Hey, wouldn't it be great if that test was no more bother than simply taking your blood pressure is?

Well, at this writing, there is such a device, currently in Clinical Trials, after 15 years of research and development in California Universities. Lexington BioSciences "HeartSentry" can measure something that has never been measured properly before. Endothelium

Endothelium, are the cells that line all arteries and are critical to the prevention of atherosclerosis, heart disease and stroke, the two leading causes of deaths worldwide (17.5 million people every year). 
The significant value of measuring endothelial function is supported by many peer-reviewed studies.

For ease of use this new, life saving technology has been incorporated into a simple blood pressure cuff.  Utilizing both blue tooth and cloud technology, the device to provide up-to-date, accurate readings of a patients complete cardiovascular health via electronic monitoring.

As you might expect, this is a significant development in a  multi-billion dollar market, and all the patents and the technology are owned by a MicroCap Business, owned and operated by PHD's - LexingtonBioSciences 

 More about HeartSentry.....


Disclosure: We own LNB Stock! 
Question: Do you? 






Behind Every Successful Company is an Elite Management Team

The principals, directors and advisers of Lexington Biosciences, Inc. (OTC: LXGTF) have been individually and collectively involved in raising extensive capital funding for their private and public companies. Team members have held numerous executive leadership positions encompassing biotechnology, and medical device companies, as well as multi-national corporations. The team includes inventors, scientists, and business people who have successfully started, built and grown multiple life science companies.

Eric Willis, Chief Executive Officer

Mr. Willis is an entrepreneurial healthcare technology executive with a track record of success in bringing products from initial concept to market. He is the past President and Chief Operating Officer of ParaPatch (2013–2015), where he was responsible for the development and launch of an over-the-counter women’s health product for the treatment of urinary incontinence. Prior to this, he served as President and CEO of InSite Medical Technologies (2008–2013) a venture backed start-up medical device company that developed a new method for performing epidural anesthesia. From 1994–2008 he served in a variety of executive and operational roles for cardiovascular medical device companies.

Doug Janzen, Chairman

Mr. Janzen has 20 years of experience in life sciences with leadership experience in corporate finance, business development, and operational management of life sciences companies. Mr. Janzen is currently Co-Founder and Managing Director of Northview Ventures. He serves as img alt Chairman and CEO of Aequus Pharmaceuticals (AQS-TSXV), a company that was founded within Northview. Prior to Northview Ventures, he was President and CEO of Cardiome Pharma (NASDAQ: CRME) During this time he raised over $300 million from investors, completed over $1 billion in licensing deals.

Greg Robertson, M.D., Medical Advisor

Dr. Greg Robertson is chief of the Emory Heart and Vascular Clinic at Johns Creek. At the Emory Johns Creek Hospital he is chief of cardiology and the medical director of the cardiac catheterization laboratory and interventional program. He is board certified in Vascular Medicine, Endovascular Medicine, Interventional Cardiology and Cardiovascular Medicine. He is an associate professor of medicine at Emory University. Dr. Robertson’s clinical expertise has focused on preventative care and using minimally-invasive vascular and cardiac treatment.

Rocco Rossi, Director

A successful entrepreneur and business executive, champion fundraiser, and dedicated public servant, Rocco Rossi is currently President and CEO of Prostate Cancer Canada. His unique blend of experience intersects general management, philanthropy, public policy, politics, business strategy, and new media. As CEO of the Heart and Stroke Foundation – one of Canada’s largest non-profit organizations – from 2004 to 2009, Rossi oversaw four consecutive years of record fundraising raising over $500 million in total and launching many new, life-saving initiatives. His passion for public policy has led him to stand for election both for the position of Mayor of Toronto and for MPP.

We believe Opportunity is Knocking

It’s not everyday you are presented with the opportunity of investing in a company that’s within a $140-billion-dollar sector, with a real chance for FDA approval, the potential opportunity to sell their product within some of the largest big box retailers on the planet, the chance to capitalize off of a hot sector with public companies currently making triple digit gains in less than 2 years & not to mention you get to be a part of the beginnings of a company that’s primary goal is to SAVE LIVES!

Wednesday, November 1, 2017

DotCom (.Com) Domain Names are still the most sought after Web Domains Online Today

Since the advent of the World Wide Web, Circa 1994, There has been one Domain extension that has soared above all the rest in value.
That is the .Com Web Domain.

Web Domains, as you probably already know, are the Real-estate of the Internet. Domains are now essential to any business today, whether it is an international, national or local business.

The importance of a good Domain Name cannot be understated. In today's busy, online world, and in the real world, Business Marketing goes on and that Marketing "must" include a solid online address.

Because it was the first domain extension associated with business, the .Com has become synonymous with online business and Domains like Business.com, Yahoo.com, Google.com, Ebay.com, Sex.com, Porn.com, Apple.com, Twitter.com, Facebook.com etc etc have been valued in the tens of millions of dollars.


Thousands more have been bought and sold for millions or in the high six figures, and millions of .com Domains have been sold in the tens of thousands of dollars. To view this year's "year to date" sales chart/list visit: >> http://dnjournal.com/ytd-sales-charts.htm

If you have the time, For more of a historical research of domain sales, go to: http://dnjournal.com/archive/domainsales-archive.htm


At RetireFund.com, we still have some Dot Com and Dot Net Domains for sale! Some of these were registered before the turn of the century.

Because it is our intent to exit this business for another, we have drastically reduced all prices for these Domains.

They include:


NanoMan.com

RetireFund.com

RetireFund.net

RetireFunds.com

GrapheneEngineering.com

FuturesExchange.net

OptionsExchange.net

GrapheneEngineering.com

Xomains.com

Just click on the domain of your choice to see the asking price, or to make an offer!

Good luck with your business!

HP






Sunday, September 10, 2017

Money is synonomous with Domain Names ***AND*** Domains are synonomous with Money. Dot Money names now available!

The world of Web Domains is changing once again, and, some say, for the better.

Not only can you buy, own or register .com .net and .org domains, but you can now register or buy many other domain extensions.

  A most interesting recent addition to domain extensions is the
.Money Domain.

 At the same time, Crypto Currencies like Bitcoin, Ethereum, Litecoin, Dash etc., are beginning to dominate the financial news.

Since we are in the business we thought it only prudent to bolster our Retirefund portfolio with this new Money extension.  

Here are some of the .MONEY Domains now on auction!


StockMarkets.Money

NYSE.Money

Nasdaq.Money

Tsx.Money

Euros.Money

Buck.Money

4x.Money

BTcoin.Money

BitBank.Money

BitWallet.Money
  
Ethers.Money
Eths.Money 


Ripples.Money

RPLE.Money

Nems.Money

Neos.Money

Cryptos.Money

itCoin.Money

Wallets.Money

BankCards.Money

Bnk.Money

Tex.Money

Bots.Money

Doll.Money

Hide.Money

Americans.Money

Rupees.Money

Yuans.Money
 
Incomes.Money

IncomeTax.Money

 

 You can bid on any or all of these Money Web
Domains now at:

Xomains.Com

or just click the domain of your choice!